Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

Published 27/09/2022, 11:29
Updated 27/09/2022, 12:10
© Reuters.  Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

© Reuters. Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

Gainers

  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
  • Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 25.2% to $0.4199 in pre-market trading. Grom's Curiosity Ink Media announced that the company Secured the husband-wife writing team, Chelsea and Matt Giegerich, to pen the storyline for 'The Pirate Princess.'
  • Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) shares rose 16.2% to $0.9763 in pre-market trading. Faraday Future Intelligent Electric shares gained around 10% on Monday after the company announced FF Top will dismiss its lawsuit against the company and its board of directors. The company also announced a new $100 million financing commitment.
  • BIT Mining Limited (NYSE: BTCM) rose 15.4% to $0.30 in pre-market trading after declining around 9% on Monday.
  • Bakkt Holdings, Inc. (NYSE: BKKT) rose 15.1% to $2.52 in pre-market trading. Bakkt Holdings recently appointed Chip Goodroe as its Chief Accounting Officer.
  • Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) rose 14.2% to $11.99 in pre-market trading.
  • Intelligent Living Application Group Inc. (NASDAQ: ILAG) rose 13.2% to $2.31 in pre-market trading after gaining over 11% on Monday.
  • ContraFect Corporation (NASDAQ: CFRX) rose 13% to $0.20 in pre-market trading. ContraFect, last month, said it continues to advance lead programs toward new clinical studies and expects to file with regulatory authorities later this year to initiate a study of intra-articular exebacase in chronic or recurrent prosthetic joint infections.
  • BitNile Holdings, Inc. (NYSE: NILE) rose 12.1% to $0.2075 in pre-market trading.
  • CorpHousing Group Inc. (NASDAQ: CHG) rose 10.3% to $1.80 in pre-market trading. CorpHousing Group posted Q2 EPS of $0.04.
  • Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 9.6% to $4.08 in pre-market trading. Helix Energy Solutions recently announced two-year contract extension with Petrobras for Siem Helix 2.
  • TechnipFMC plc (NYSE: FTI) rose 9.5% to $8.84 in pre-market trading. TechnipFMC was recently awarded a significant subsea contract for Shell (LON:RDSa)'s North Sea Development.
  • Akebia Therapeutics, Inc. (NASDAQ: AKBA) rose 8.3% to $0.3333 in pre-market trading. Akebia Therapeutics, last month, announced initial findings from an investigator-sponsored study evaluating vadadustat for Acute Respiratory Distress Syndrome (ARDS) with COVID-19 and hypoxemia.
  • Geron Corporation (NASDAQ: GERN) rose 5.8% to $2.39 in pre-market trading. Geron, last month, dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).
  • PureCycle Technologies, Inc. (NASDAQ: PCT) rose 5.8% to $8.89 in pre-market trading.
  • I-Mab (NASDAQ: IMAB) rose 5.5% to $4.80 in pre-market trading. I-Mab recently announced approval from China CDE to initiate Phase 3 registrational study of lemzoparlimab in combination with azacitidine in higher-risk myelodysplastic syndrome.

Don’t forget to check out our premarket coverage here .

Losers

  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 23.6% to $0.6490 in pre-market trading. Aridis Pharmaceuticals announced a proposed public offering of common stock.
  • Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares fell 21.6% to $5.61 in pre-market trading. Kiora Pharmaceuticals said its stockholders authorized a reverse stock split of its common stock.
  • FedNat Holding Company (NASDAQ: FNHC) fell 11% to $0.20 in pre-market trading after dropping over 15% on Monday.
  • CarLotz, Inc. (NASDAQ: LOTZ) fell 9.4% to $0.3126 in pre-market trading after gaining over 5% on Monday. Shift Technologies and CarLotz, last month, announced they have entered into a definitive agreement to combine in a stock-for-stock merger.
  • HeartBeam, Inc. (NASDAQ: BEAT) fell 8.1% to $2.28 in pre-market trading after surging 22% on Monday.
  • Kaixin Auto Holdings (NASDAQ: KXIN) fell 7.7% to $0.9041 in pre-market trading after gaining 5% on Monday..
  • Inpixon (NASDAQ: INPX) fell 7.4% to $0.1303 in pre-market trading. Inpixon shares jumped over 21% on Monday after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business.
  • Troika Media Group, Inc. (NASDAQ: TRKA) shares fell 7% to $0.3510 in pre-market trading after declining 6% on Monday.
  • InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 6.7% to $3.86 in pre-market trading after declining over 6% on Monday.
  • AMTD Digital Inc. (NYSE: HKD) shares fell 4.5% to $62.02 in pre-market trading.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.